Morgens Waterfall Vintiadis & CO Inc Agios Pharmaceuticals, Inc. Transaction History

Morgens Waterfall Vintiadis & CO Inc

  • $118 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$31.52 - $53.81 $661,920 - $1.13 Million
-21,000 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$30.08 - $50.59 $631,680 - $1.06 Million
21,000 New
21,000 $1 Million
Q2 2019

Aug 14, 2019
SELL
$46.17 - $68.1 $646,380 - $953,399
-14,000 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$45.92 - $67.67 $642,880 - $947,380
14,000 New
14,000 $944,000

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.26B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Morgens Waterfall Vintiadis & CO Inc Portfolio

Follow Morgens Waterfall Vintiadis & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email